Liposome bupivacaine (EXPAREL®) for extended pain relief in patients undergoing ileostomy reversal at a single institution with a fast-track discharge protocol: an IMPROVE Phase IV health economics trial

BACKGROUND: Postoperative opioid use following ileostomy reversal procedures contributes to postoperative ileus. We assessed the impact of a liposome bupivacaine-based, opioid-sparing multimodal analgesia regimen versus a standard opioid-based analgesia regimen on postsurgical opioid use. We also as...

Descripción completa

Detalles Bibliográficos
Autor principal: Vogel, Jon D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3735342/
https://www.ncbi.nlm.nih.gov/pubmed/23935387
http://dx.doi.org/10.2147/JPR.S46950

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3735342/
https://www.ncbi.nlm.nih.gov/pubmed/23935387
http://dx.doi.org/10.2147/JPR.S46950

Ejemplares similares